We are live on ! Find out more
Clearstead Advisors

Clearstead Advisors Portfolio holdings

AUM $10.8B Turnover 17.48%
1-Year Est. Return 17.88%
 

Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.

This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+17.88%
3 Year Est. Return
+79.54%
5 Year Est. Return
+82.82%
10 Year Est. Return
+264.8%
AUM
$10.8B
AUM Growth
+$198M
Cap. Flow
+$184M
Cap. Flow %
1.7%
Top 10 Hldgs %
29.69%
Holding
3,935
New
268
Increased
1,353
Reduced
1,363
Closed
420
Avg Time Held Equity + Options
2.3 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
3.2 years
Avg Time Held Equity only
2.3 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
3.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.02%
2 Technology 12.85%
3 Industrials 7.3%
4 Financials 5.21%
5 Consumer Discretionary 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GMAB icon
1701
Genmab
GMAB
$32B
$23.4K ﹤0.01%
656
+14
+2% +$443
2023 Q3
12 quarters
UTHR icon
1702
United Therapeutics
UTHR
$24.9B
$23.3K ﹤0.01%
43
– –
2025 Q1
6 quarters
EGP icon
1703
EastGroup Properties
EGP
$10.4B
$23.3K ﹤0.01%
118
-602
-84% -$124K
2021 Q2
21 quarters
GALT icon
1704
Galectin Therapeutics
GALT
$293M
$23.3K ﹤0.01%
6,000
– –
2023 Q2
13 quarters
THC icon
1705
Tenet Healthcare
THC
$22.4B
$23.3K ﹤0.01%
91
-80
-47% -$19.7K
2024 Q2
9 quarters
TLX icon
1706
Telix Pharmaceuticals
TLX
$3.01B
$23.2K ﹤0.01%
2,112
– –
2026 Q2
1 quarter
ZIM icon
1707
ZIM Integrated Shipping Services
ZIM
$3.58B
$23K ﹤0.01%
+786
New +$21.2K
2026 Q3
0 quarters
TTD icon
1708
Trade Desk
TTD
$7.06B
$23K ﹤0.01%
1,889
+216
+13% +$3.39K
2020 Q1
26 quarters
LSTR icon
1709
Landstar System
LSTR
$5.09B
$22.9K ﹤0.01%
136
-153
-53% -$28.4K
2024 Q2
9 quarters
VFC icon
1710
VF Corp
VFC
$8.01B
$22.9K ﹤0.01%
1,630
-1,016
-38% -$15.1K
2020 Q1
26 quarters
MLI icon
1711
Mueller Industries
MLI
$11.7B
$22.9K ﹤0.01%
378
-450
-54% -$28K
2022 Q4
15 quarters
GEN icon
1712
Gen Digital
GEN
$17.5B
$22.9K ﹤0.01%
1,043
-174
-14% -$4.83K
2024 Q3
8 quarters
STXF icon
1713
Strive 500 ETF
STXF
$1.13B
$22.9K ﹤0.01%
464
+1
+0.2% +$49
2023 Q1
14 quarters
VNQI icon
1714
Vanguard Global ex-US Real Estate ETF
VNQI
$3.29B
$22.8K ﹤0.01%
+536
New +$24.1K
2026 Q3
0 quarters
IDA icon
1715
Idacorp
IDA
$8.42B
$22.6K ﹤0.01%
173
-101
-37% -$14.2K
2025 Q2
5 quarters
DT icon
1716
Dynatrace
DT
$12.4B
$22.5K ﹤0.01%
390
-1,396
-78% -$69K
2023 Q2
13 quarters
AIS icon
1717
VistaShares Artificial Intelligence Supercycle ETF
AIS
$829M
$22.4K ﹤0.01%
300
– –
2026 Q2
1 quarter
PS icon
1718
Pershing Square
PS
$17.4B
$22.4K ﹤0.01%
+400
New +$15.8K
2026 Q3
0 quarters
MKSI icon
1719
MKS
MKSI
$14B
$22.3K ﹤0.01%
84
-76
-48% -$22.5K
2023 Q3
12 quarters
DOCS icon
1720
Doximity
DOCS
$5.55B
$22.2K ﹤0.01%
783
+247
+46% +$5.97K
2023 Q4
11 quarters
EVR icon
1721
Evercore
EVR
$11B
$22.1K ﹤0.01%
86
-161
-65% -$49K
2023 Q3
12 quarters
RTO icon
1722
Rentokil
RTO
$11.8B
$22.1K ﹤0.01%
1,121
+257
+30% +$6.45K
2026 Q2
1 quarter
PINS icon
1723
Pinterest
PINS
$10.4B
$21.9K ﹤0.01%
1,160
+730
+170% +$16K
2020 Q3
24 quarters
FXI icon
1724
iShares China Large-Cap ETF
FXI
$3.77B
$21.9K ﹤0.01%
644
– –
2025 Q4
3 quarters
GLNG icon
1725
Golar LNG
GLNG
$4.28B
$21.9K ﹤0.01%
460
– –
2026 Q1
2 quarters

Similar funds

Clearstead Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, Clearstead Advisors held 3,935 positions worth $10.8B, up 1.9% from $10.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Clearstead Advisors's Q3 2026 filing shows 268 new, 1,353 increased, 1,363 reduced and 420 closed positions. Its largest new stake was Criteo: 105,734 shares worth $1.61M. The largest sale was Capital Group Global Equity ETF, an estimated $34.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.

  • Clearstead Advisors's largest Q3 2026 buy was Criteo: 105,734 shares worth $1.61M.
  • Clearstead Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2026, an estimated $95.3M increase.
  • Clearstead Advisors's biggest Q3 2026 reduction was Capital Group Global Equity ETF, cutting an estimated $34.4M.
  • Clearstead Advisors fully exited iShares 0-5 Year High Yield Corporate Bond ETF in Q3 2026, selling an estimated $11.5M.
  • Clearstead Advisors's ten largest holdings make up 30% of its $10.8B portfolio in Q3 2026.
  • Clearstead Advisors opened 268 new positions and closed 420 in Q3 2026.
  • Clearstead Advisors's portfolio value rose 1.9% quarter-over-quarter to $10.8B.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.